| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | China | 4 | |
| #4 | EPO (European Patent Office) | 3 | |
| #5 | Mexico | 3 | |
| #6 | Australia | 2 | |
| #7 | Brazil | 2 | |
| #8 | Canada | 2 | |
| #9 | Israel | 2 | |
| #10 | New Zealand | 2 | |
| #11 | South Africa | 2 | |
| #12 | Chile | 1 | |
| #13 | United Kingdom | 1 | |
| #14 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Frenneaux Michael Paul | 22 |
| #2 | Ashrafian Houman | 18 |
| #3 | Houman Ashrafian | 4 |
| #4 | Paul Frenneaux Michael | 3 |
| #5 | Michael Paul Frenneaux | 2 |
| #6 | Ashrafian Houman Freeenaux Michael Paul | 1 |
| #7 | M P Franks | 1 |
| #8 | Shalwitz Robert Alan | 1 |
| #9 | H Aschirafen | 1 |
| #10 | Frenneaux Michael P | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2017153850A1 | Perhexiline dosing regimens for use in the treatment of hypertrophic cardiomyopathy | |
| JP2015147787A | Treatment of heart failure with normal ejection fraction | |
| AU2010247120A1 | Perhexiline for use in the treatment of hypertrophic cardiomyopathy (HCM) | |
| AU2009346606A1 | Treatment of heart failure with normal ejection fraction | |
| NZ625344A | Treatment of heart failure with normal ejection fraction | |
| GB0723100D0 | Treatment of HFnEF |